055550:KRX
Shinhan Financial Group Co., Ltd.
Data as of 2026-03-10 - not real-time
₩89,200.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Shinhan Financial Group trades around KRW 89,200, well below the analyst median target of KRW 110,000, implying roughly a 24% upside. Forward P/E of 7.1 is dramatically lower than the industry average of 17.4, signaling an undervalued position. The stock offers an attractive dividend yield of 3.98% with a modest payout ratio of 22.9%, suggesting sustainable cash returns. Fundamentals are solid: revenue growth of 21.6% YoY, operating margin of 36.7% and ROE of 8.5% underline strong profitability. Technicals are mixed – the price sits below the 20‑day SMA (96,720) but above the 50‑day and 200‑day SMAs, the RSI is neutral at 44, and a bearish MACD histogram signals short‑term momentum weakness. Nonetheless, the broader market sentiment is extremely bullish (Fear & Greed Index 81) and volume is increasing, supporting a longer‑run buying case.
The low beta of 0.42 indicates limited market‑wide volatility, yet the 30‑day price volatility is high at 50%, flagging short‑term price swings. With a max drawdown of just 16.5% and a strong analyst consensus ("strong buy" from 21 analysts), the risk‑adjusted profile is appealing. The combination of deep valuation discount, robust dividend, and solid earnings growth makes Shinhan a compelling candidate for medium‑ to long‑term investors, while traders should remain cautious of the current bearish MACD and price positioning relative to the short‑term SMA.
The low beta of 0.42 indicates limited market‑wide volatility, yet the 30‑day price volatility is high at 50%, flagging short‑term price swings. With a max drawdown of just 16.5% and a strong analyst consensus ("strong buy" from 21 analysts), the risk‑adjusted profile is appealing. The combination of deep valuation discount, robust dividend, and solid earnings growth makes Shinhan a compelling candidate for medium‑ to long‑term investors, while traders should remain cautious of the current bearish MACD and price positioning relative to the short‑term SMA.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram indicating weakening momentum
- Price below 20‑day SMA suggesting short‑term support pressure
- High 30‑day volatility (≈50%) increasing near‑term risk
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward P/E of 7.1 vs industry 17.4 – strong valuation upside
- Sustainable dividend yield of 3.98% with low payout ratio
- Revenue growth of 21.6% and operating margin of 36.7% supporting earnings expansion
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistent ROE of 8.5% indicating efficient capital use
- Low beta (0.42) reducing market‑wide systematic risk
- Analyst consensus of strong‑buy and target price 24% above current level
Key Metrics & Analysis
Financial Health
Revenue Growth21.60%
Profit Margin31.62%
P/E Ratio7.1
ROE8.53%
ROA0.67%
Op. Cash Flow₩-14362386366464
Industry P/E17.4
Technical Analysis
TrendBullish
RSI44.2
Support₩0.00
Resistance₩107,200.00
MA 20₩96,720.00
MA 50₩87,132.00
MA 200₩73,144.00
MACDBearish
VolumeIncreasing
Fear & Greed Index81.02
Valuation
Target Price₩110,804.77
Upside/Downside24.22%
GradeUndervalued
TypeBlend
Dividend Yield3.98%
Risk Assessment
Beta0.42
Volatility50.46%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
More Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.